Pamela Munster

Academic / Other · 8 registered clinical trials — 1 currently recruiting.

Status	Trial	Phase	Started
Recruiting	Olaparib and ASTX727 in BRCA1/2- and Homologous Recombination Deficient (HRD)-Mutated Tumors BRCA1 Mutation, BRCA2 Mutation, BRCA Mutation	Phase 1	2024-02-07
Withdrawn	Alpelisib in Combination With Carboplatin in Patients With Solid Tumors and HPV-Positive Squamous Cell Carcino Solid Tumors, Adult, PIK3CA Mutation-Related Tumors, PIK3CA Mutation	Phase 1	2022-11-01
Withdrawn	Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8	Phase 1	2021-03-31
Completed	Rucaparib and Irinotecan in Cancers With Mutations in DNA Repair Solid Tumor, Unspecified, Adult	Phase 1	2018-01-12
Terminated	Phase Ib Study of Alpelisib With Cisplatin in Patients With HPV+ Solid Tumor Malignancies Solid Tumors	Phase 1	2016-12-01
Withdrawn	64-Cu Labeled Brain PET/MRI for MM-302 in Advanced HER2+ Cancers With Brain Mets Brain Metastases, Documented Her2 Overexpression, Advanced Solid Tumor	EARLY_Phase 1	2016-04-01
Terminated	Study of BMN-673 With Carboplatin and Paclitaxel in Patients With Advanced BRCA-mutated Solid Tumor or Triple Triple Negative Metastatic Breast Cancer, BRCA-mutated Solid Tumor	Phase 1	2015-02-23
Completed	Pazopanib in Combination With PCI-24781 in Patients With Metastatic Solid Tumors Metastatic Solid Tumors	Phase 1	2012-06-25